Molecular hybridization with radioactively labeled DNA complementary to the RNA of the Rauscher leukemia virus was used to probe for homologous RNA in the polysome fraction of human leukemic cells. The leukocytes of 24 out of 27 patients examined contained RNA possessing homology to that of the mouse leukemia agent, but not to that of the unrelated viruses causing mammary tumors in mice or myeloblastosis in chickens. Further, no control human leukocytes or other adult and fetal tissues showed significant levels of the leukemia-specific RNA. I t would appear that human leukemic cells contain RNA sequences homologous to those found in a viral agent known to cause leukemia in an experimental animal. The fact that human sarcomas have also been shown to contain this type of RNA points to a remarkable parallelism in the leukemias and sarcomas of mice and men.
The search for evidence implicating oncogenic RNA viruses in human neoplasia constitutes a major endeavor in presentday cancer research. One approach recently explored stemmed from an attempt to determine via RNA-DNA hybridization (1) whether human breast carcinomas contain RNA molecules homologous to an analogous virus of proven oncogenic potential. Human breast cancer was chosen for the initial effort because of the recent observations (2) in human milk of particles similar to the mouse mammary tumor virus and the demonstration (ref. 3 and manuscript in preparation) that the human particles also contain the enzyme and high molecular weight (70s) RNA characteristic of the animal RNA tumor viruses.
As a necessary prelude to attempts with human material, we examined the technical feasibility of using the molecular hybridization technique with mouse mammary tumors and the corresponding viral agent as a suitable experimental model. Hybridizations with radioactively labeled DNA complementary to the RNA of the mouse mammary tumor virus revealed (4) that it was in fact possible to identify in tumor extracts viral-specific RNA in the fraction of ribosomes actively engaged in protein synthesis.
The experiments with the mouse model produced the detailed technology required to handle human tissue specimens. The mouse mammary tumor virus was chosen to produce the radioactively labeled DNA needed to search for homologous RNA in human tumors. The results obtained (5) were satisfyingly clear-cut. Of 29 malignant breast tumors examined, 67% showed unmistakable evidence of RNA that can hybridize with mouse mammary tumor virus DNA. None of the 30 preparations from normal or nonmalignant breast tissues contained detectable quantities of this type of RNA.
Abbreviation: RLV, Rauscher leukemia virus
Further, the malignant RNA samples that hybridized with mouse mammary tumor virus DNA showed no ability to complex with DNA complementary to the RNA of two leukemogenic agents, the avian myeloblastosis virus and the murine Rauscher leukemia virus.
These last observations in particular gave added credence to the belief that the positive responses observed between RNA from malignant human breast tumors and the mouse-viral DNA were specific and meaningful. In any event, as soon as it became apparent that the experiments with breast tumor material were yielding interesting results, the present investigation into human leukemia, and a parallel one in human sarcomas (manuscript in preparation), were instituted.
A particle of established leukemogenic potential, the murine Rauscher leukemia virus (RLV) , was chosen to produce the radioactively labeled DNA required. We report here that 89% of leukemic patients in the active phase of the disease contained, in their leukocytes, RNA possessing homology to that of the Rauscher leukemia virus but not to the RNAs of the unrelated mouse mammary tumor virus or the avian myeloblastosis virus. Further, no control leukocytes or other tissues examined showed significant levels of this specific RNA.
METHODS
Leukocytes were obtained by fractionation of citrated blood samples in inverted syringes. Leukemic cells prepared in other laboratories were sent to us frozen in dry ice. The cells were collected by centrifugation, washed in saline, and then suspended in 0.01 M Tris.HC1 (pH 7.4)-0.15 M NaC1-2 mM MgClz containing 5y0 sucrose. They were ruptured with 5-12 strokes of a Dounce homogenizer. Cell membranes and nuclei were removed and the cytoplasmic pellets were collected and used for the isolation of polysomal RNA (4). All annealings were a t 37°C in 50% formamide, to minimize fragmentation of the RNA during the hybridization. Hybrids were detected by isopycnic separation in CszS04 gradients (6).
RESULTS
For comparison, and to see what might be optimally expected with human material, it was of interest to examine the outcomes of analogous hybridizations in instances of two animal leukemias known to be associated with a viral agent. Fig. IA shows the result of hybridization of In studies such as these, it must be shown before use that the radioactive DNA product bands solely in the DNA density region of a CszSo4 gradient and that it hybridizes with homologous RNA and not to normal cellular RNA.
The RNA (designated a5 pltNA) used in the hybridizations is derived from a cytoplasmic pellet consisting of a mixture of monosomes and polysomes (4). Suitable care must be exercised to insure the complete removal of protein contaminants. For the preparation of polysomal RNA, the spleen was disrupted by a Silverson homogenizer a t 4°C in two volumes of 5y0 sucrose in TNM buffer [0.01 M Tris.HC1 (pH 7.4)-0.15 M NaCl-2 mM MgCIz]. The suspension was centrifuged a t 20,000 g for 15 min a t 0°C. The supernatant fluid was then layered on 20 ml of 25% sucrose in TNM buffer containing 200 pg of polyvinyl sulfate per ml and spun for 180 min at 180,000 X g in a 60 Ti rotor (Spinco). The pellet was resuspended in TNM buffer with 0.5yo sodium dodecyl sulfate and the RNA was extracted twice with an equal volume of cresol-phenol (pH 8.0). Nucleic acid was precipitated from the aqueous phase by addition of two volumes of ethanol and 0.1 volume of 4 M NaCl. The polysomal RNA was redissolved in .50%) for1namide-.507~ 5 niM EDTA. The [3H]DNA was denatured by incubation a t 80°C for 15 min in 7oy0 formamide and subsequent quick chilling. 480 pg of polysomal RNA were hybridized to 2000 cpm of RLV-[3H]DNA in 60 pl of 0.4 M NaCL containing 50% formamide. The reaction was incubated for 18 hr a t 37"C, mixed with 10 ml of 50%-saturated CszSO4 (starting density 1.52) and centrifuged at 44,000 cpm for 60 hr a t 20°C in a , SO Ti rotor (Spinco). 0.4-ml @-drop) Fractions were collected through an 18-gauge needle from the bottom of the tube and assayed for Cl&COOH-precipitable radioactivity. molecule in the complex is much larger than the 4 S-6 S average size of the product DNA. Fig. 1B shows the similar outcome with a rat ascitic monocytic leukemia, originally induced (7) with 2O-methy1cholanthreneJ that produces low levels of a C-type particle (8) somal RNA preparations derived from human-leukemic leukocytes (buffy coats). As may be seen, the results are comparable to those obtained with the animal systems ( Fig. 1A and B ) . I n Fig. 2A, 15y0 of the input RLV-DNA is hybridized; the other three samples gave 3-5% formation of the hybrid complex. Again, as in the hybridizations with polysomal R N A from the animal leukemic material (Fig. 1A and B ) , the locations of the complexes in the gradients of Fig. 2 indicate that the RNA is much larger than the DNA, and determines the density of the DNA-RNA hybrid structure. The positive responses observed ( Fig. 2A-D reactions with polysomal RNAs from normal leukocytes (Fig. 3A) , from phytohemagglutinin-stimulated lymphocytes (Fig. 3B) , from leukocytes of a leukemic patient in clinical remission (Fig. 3C) , and from human fetal lung (Fig. 30) . In none of these samples does one find significant amounts of taH]DNA in the RNA region of the density gradient.
An informative way t o compare positive and negative reactions is via a concentration curve, as shown in Fig. 4 (Fig. 4) .
Since it is impractical to present the Cs2S04 gradient profile of every sample examined, a more convenient recording of our findings was used. After correction for background counts, the sum of the tritium counts in the RNA density region (between densities 1.62 and 1.68 g/ml) was used to measure the amount of DNA complexed to RNA. To achieve the accuracy desired, 10-min counts were taken on each sample. An operational mean background and its standard deviation ( S ) were empirically determined for individual machines by the total counts/lO min of three tubes in the negative regions (e.g., tubes 2, 3, and 4) of each of 60 gradients. The convention was adopted that all specimens with less than three standard deviations of the background mean counts/lO min would be considered negative. w.
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FIG. 3. (A-D)
CszSC.4 density centrifugation of RLV-L3H]-DNA after annealing to polysomal RNA isolated from ( A ) normal white buffy coat, ( B ) phytohemagglutinin-stimulated lymphocytes ( C ) , buffy coat of a leukemic patient in clinical remission, and (D) fetal lung. The polysomal RNA input was 300 pg, except in ( C ) where 1000 pg were used per 60-p1 hybridization reaction. Subsequent analysis on CszSOa was described in Fig. 1 . (Table 1 ) and various control tissues.
Of the 27 leukemic samples examined, only three fell in the negative range. The remaining 24 showed positive reactions, with some exceeding those observed with the animal leukemic material ( Fig. IA and B ) . I n contrast, none of the polysomal RNA preparations from 33 normal tissues gave a reaction that could be unambiguously designated as positive. These preparations include RNAs from normal leukocytes, phytohemagglutinin-stimulated lymphocytes, and various normal human adult and fetal tissues.
The fact that 89% of the leukemic polysomal RNAs yielded unmistakable positive hybridizations with RLV-DNA , whereas none of the 33 control tissues exhibited this type of response, argues for the specificity of the annealing reactions.
Further support for this conclusion can be obtained by the use of a [3H]DNA complementary t o the RNA of the mouse mammary tumor virus or t o that of the avian myeloblastosis virus. We have shown (manuscript in preparation) t h a t RLV-DNA and the homologous viral RNA do not crosshybridize significantly with the corresponding nucleic acids of either the mammary tumor virus or the avian agent. If the annealing reaction is specific, one would not expect a leukemic polysomal RNA, positive for a reaction with RLV-DNA t o show the ability t o hybridize either with mouse mammary tumor viral-DNA or avian myeloblastosis viral-DNA. Fig. 6 shows that these expectations are realized. None of three other leukemic polysomal RNAs giving a positive (550-910 counts/lO min above background) reaction with RLV-DNA responded to either of the other two viral DNAs.
Stimulated by the known viral etiology of animal leukemias (9, 10) , others have sought for similar evidence in the human disease. Particles resembling the C-type viruses of the avian and murine leukemias have been occasionally detected by electron microscopy (11). Of perhaps more immediate relevance is the report (12) of components in human leukemic cells and sera that can interact with fluorescent-labeled antibodies against the Rauscher leukemia virus.
The present investigation is not directly aimed at resolving the issue of a viral etiology of human cancer. It is concerned rather with determining whether viral-related information, in terms of sequence similarities, can be detected in human neoplastic cells.
It is worth explicitly noting the questions that remain unanswered by the data described here. They provide no measure of the degree of homology between the RLV-DNA and the R N A detected in human leukemic cells. T o settle this issue will require the synthesis of RLV-DNA in amounts adequate t o permit comparative saturation curves of labeled RLV-RNA and the relevent RNA strands from human leukemic cells. The fact that hybrids are found in the RNA region of the density gradient implies that the RNA is much larger than the DNA product. However, experiments must now be designed and performed that will determine how large this RNA is, how much viral sequence it contains, and whether the viral information is covalently linked to normal cellular message. The latter point is particularly relevant to whether the viral information is integrated into the genome of the cancer cell. Finally, more highly purified mRNA fractions will be required to make the quantitative aspects more certain. I n particular, it is apparent that a negative outcome of a hybridiza- From the data presented, one can conclude at best that the probability of finding RNA homologous to Rauscher leukemia viral RNA is much greater in human leukemic cells than in normal tissues. Indeed, if the provirus (13) or oncogene hypotheses (14) are valid, some part of this information might be found with more sensitive tests in presumably normal cells derived from fetal tissues or phytohemagglutinin-stimulated lymphocytes, both of which have been reported (14, 15) to possess the group-specific antigen of the mammalian leukeniogenic viruses.
While the experiments described here do not constitute definitive proof of a viral etiology of human leukemia, they provide rather compelling evidence for the presence in human leukemic cells of RNA posessing sequences homologous t o those found in a viral agent known to cause leukemia in a n experimental animal. From what we know of animal systems, one would predict that a similar situation would be found in human sarcomas, a prediction that has been confirmed and will be detailed in another publication.
